NewsRoom Articles - Page 67 of 214

MondayJul 24, 2023 1:11 pm

Psoriasis Could Be Behind Frequent Fatigue

Psoriasis is a topical condition that causes dry, scaly and itchy patches to develop on the skin around the scalp, trunk, elbows and knees. The condition is chronic and is typically managed using medication to alleviate symptoms, coping strategies and different lifestyle habits to minimize the number of triggers in your life. Even though psoriasis typically acts on the skin, with its symptoms generally affecting different areas of the skin, studies have found that psoriasis may also cause exhaustion. Exhaustion is something we all experience every day. It is a normal part of the human experience that is essentially the…

FridayJul 21, 2023 12:55 pm

2023 Prime Day Sets eCommerce Record

Online retailers on Amazon reported record sales numbers during the recent Prime Day summer sales event, selling more than $12.7 billion worth of product in two days and setting an eCommerce record. Held every year, the summer sale is a members-only event that grants customers exclusive discounts on thousands of different products across nearly every category on the platform. Amazon-only products such as Echo smart speakers, Kindles, Fire Tablets and Fire TV Sticks offered the highest discounts, and even subscription services such as Amazon Music Unlimited were on sale. The event ran from July 11 to 12, 2023, and offered…

FridayJul 21, 2023 9:00 am

National GBM Awareness Events Underscore Significance of Clinical Trial Progress for CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)

National awareness of glioblastoma tumors (“GBM”) sustained by Congressional leaders aim to improve efforts to treat brain cancers and ultimately improve patient survival GBM is a widely occurring, aggressive and effectively incurable brain cancer that few patients survive beyond three years U.S.-based drug developer CNS Pharmaceuticals is in the midst of a global potentially pivotal clinical trial for its lead pharmaceutical candidate, Berubicin, which it aims to show improves on standard of care chemotherapy agent Lomustine’s approach to treating GBM Berubicin is a novel anthracycline that is practically unique in its ability to cross the blood-brain barrier to directly target…

ThursdayJul 20, 2023 2:33 pm

How to Cope When SSRIs Affect Your Sex Life

An estimated 37 million Americans are currently taking some kind of selective serotonin reuptake inhibitors (SSRIs) to treat depression. SSRIs are among the most effective depression medications on the market with a moderate success rate of around 40 to 60% and remission rates of 30% to 45%. However, SSRI use is also associated with the occurrence of side effects ranging from mild ones such as nausea, dizziness and headaches to insomnia and a variety of sexual problems. Patients who use SSRIs to alleviate depression symptoms often report sexual side effects, such as difficulty becoming aroused and reaching orgasm. Some individuals…

WednesdayJul 19, 2023 3:01 pm

Doctors Use Melanoma Drugs to Shrink Brain Tumors by 90% in Small Study

Researchers from Mass General Cancer Center’s Central Nervous System Metastasis Center have devised a way to shrink brain tumors by up to 90% using already existing drugs. The researchers used two cancer drugs approved to treat melanoma to treat papillary craniopharyngioma (PCP), a rare type of brain cancer with a 10-year average survival rate. The researchers recruited 16 patients who had not gone through radiation therapy and gave them cancer drugs targeting the proteins MEK and BRAF, which play a role in cell growth. Surprisingly, the drugs were more than 90% effective at shrinking tumors even though they are only…

WednesdayJul 19, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) CEO Amir Reichman Featured on IBN’s The Bell2Bell Podcast

Reichman discusses BiondVax’s 2023 achievements, including the development of innovative NanoAbs in collaboration with the Max Planck Institute targeting interleukin-17 (IL-17) targeting diseases such as psoriasis Annual sales for current anti-interleukin-17 monoclonal antibodies now total about $7.5 billion annually – and BiondVax is positioned to penetrate this market with promising results Investor Brand Network (“IBN”) recently announced the release of its latest episode of The Bell2Bell Podcast, featuring Amir Reichman, CEO of BiondVax Pharmaceuticals (NASDAQ: BVXV). The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries – like BiondVax’s innovative platform technology using alpaca-derived nanosized…

TuesdayJul 18, 2023 11:06 am

Shining the Spotlight on Asthma During Pregnancy

Asthma is a respiratory condition that affects around 9.7% of adult women and 6.2% of adult males. Researchers believe the condition is more prevalent in girls and women as fluctuating levels of hormones, including progesterone and estrogen, can affect a woman’s airways. For women with asthma, pregnancy comes with additional risks. Pregnancy by itself is a risky endeavor that often puts incredible mental and physical strain on expectant mothers. With the presence of asthma, pregnant asthmatic women can find it extra hard to breathe during asthma attacks; such attacks can reduce the amount of oxygen going to the fetus and…

MondayJul 17, 2023 2:47 pm

Personalization Tactics Healthcare eCommerce Companies Can Implement

The combination of healthcare and eCommerce may be a game changer for America’s struggling healthcare sector. eCommerce has essentially taken over most aspects of trade, with major eCommerce companies such as Amazon, Alibaba and Walmart ranking among the largest companies in the world. Healthcare and eCommerce started to come together when the coronavirus pandemic forced multitudes of people to rely on the internet to interact with their physicians and access treatment. Several years later, healthcare eCommerce is picking up more steam amid buyouts of digital healthcare businesses by companies such as Amazon that are looking to expand to the healthcare…

FridayJul 14, 2023 11:37 am

Harvard Scientists Create AI Tool to Provide Real-Time Genetic Analysis of Brain Cancer During Surgery

Scientists from Harvard University have created an artificial intelligence (AI) tool that would enable physicians to do real-time genetic analysis of brain tumors during surgery. Brain tumors often have poor treatment outcomes because their proximity to the brain makes treating them effectively more difficult compared to tumors in other locations. Furthermore, limited information on a tumor’s genetics can make it harder for physicians to make treatment choices such as how much of the tumor to remove via surgery or how to administer cancer-killing drugs. With the new AI tool, neurosurgeons would be able to decode the molecular code of a…

ThursdayJul 13, 2023 1:12 pm

Observational Study Finds Minimal Patient Participation in Eczema Clinical Trials

Data shows that 1 in 10 Americans is currently living with eczema, a topical condition that reduces the skin’s barrier function and leads to the formation of itchy, dry bumps on the skin. Although eczema patients can use several remedies to alleviate most eczema symptoms, the condition currently has no cure. Despite this, an observational study has found that few patients choose to participate in eczema clinical trials despite the possibility of deriving significant benefits from new investigational therapies. According to the study, taking part in eczema clinical trials can provide better treatment options and opportunities to people with the…